Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab.
Tachinami H, Tomihara K, Yamada SI, Ikeda A, Imaue S, Hirai H, Nakai H, Sonoda T, Kurohara K, Yoshioka Y, Hasegawa T, Naruse T, Niiyama T, Shimane T, Ueda M, Yanamoto S, Akashi M, Umeda M, Kurita H, Miyazaki A, Arai N, Hayashi R, Noguchi M. Tachinami H, et al. Among authors: yamada si. Br J Oral Maxillofac Surg. 2023 May;61(4):320-326. doi: 10.1016/j.bjoms.2023.03.012. Epub 2023 Mar 31. Br J Oral Maxillofac Surg. 2023. PMID: 37061418
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan.
Otsuru M, Yamakawa N, Kirita T, Yamada SI, Kurita H, Kugimoto T, Harada H, Hasegawa T, Akashi M, Takeshita A, Uzawa N, Umeda M, Yanamoto S, Yamada T. Otsuru M, et al. Among authors: yamada si. J Dent Sci. 2024 Jul;19(3):1628-1637. doi: 10.1016/j.jds.2023.11.024. Epub 2023 Dec 14. J Dent Sci. 2024. PMID: 39035308 Free PMC article.
Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan.
Otsuru M, Yanamoto S, Yamada SI, Nakashiro K, Harazono Y, Kohgo T, Nakamura M, Nomura T, Kasamatsu A, Tanaka S, Kirita T, Kioi M, Ogawa M, Sasaki M, Ota Y, Umeda M. Otsuru M, et al. Among authors: yamada si. Int J Environ Res Public Health. 2023 Mar 3;20(5):4545. doi: 10.3390/ijerph20054545. Int J Environ Res Public Health. 2023. PMID: 36901553 Free PMC article.
Therapeutic implication of mTORC2 in oral squamous cell carcinoma.
Naruse T, Yanamoto S, Okuyama K, Yamashita K, Omori K, Nakao Y, Yamada SI, Umeda M. Naruse T, et al. Among authors: yamada si. Oral Oncol. 2017 Feb;65:23-32. doi: 10.1016/j.oraloncology.2016.12.012. Epub 2016 Dec 23. Oral Oncol. 2017. PMID: 28109464
Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.
Yokota Y, Hasegawa T, Yamakawa N, Rin S, Otsuru M, Yamada SI, Hirai E, Ashikaga Y, Yamamoto K, Ueda M, Kirita T, Umeda M, Akashi M, Kurita H, Ohiro Y, Yanamoto S, Okura M. Yokota Y, et al. Among authors: yamada si. Oral Oncol. 2023 Oct;145:106519. doi: 10.1016/j.oraloncology.2023.106519. Epub 2023 Jul 16. Oral Oncol. 2023. PMID: 37459802
Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study.
Yamakawa N, Okura M, Hasegawa T, Otsuru M, Sakai H, Hirai E, Rin S, Yamada SI, Yanamoto S, Yokota Y, Umeda M, Kurita H, Ueda M, Akashi M, Kirita T; Japan Oral Oncology Group (JOOG). Yamakawa N, et al. Among authors: yamada si. Int J Clin Oncol. 2024 Aug;29(8):1122-1132. doi: 10.1007/s10147-024-02542-y. Epub 2024 May 2. Int J Clin Oncol. 2024. PMID: 38696052
136 results